Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments

Vaccines 2012 World Market Analysis, Key Players, Trends, Pediatric and Adult Segments

• 1.
  Vaccines 2012 WorldMarket Analysis, Key Players, Trends, Pediatric and Adult Segments Report Details: Published:September 2012 No. of Pages: 249 Price: Single User License – US$3995 This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein- Barr virus (EBV) infection, ETEC infection, heart attach, Helicobacter pylori infection, multiple sclerosis, Parkinson’s disease, West Nile virus (WNV) infection, etc.; vaccines that address these and other not-yet-vaccine-preventable conditions are discussed in Kalorama’s new report, “What's Next in Vaccines.” The vaccine industry has seen changes in the past year, and these are covered in this report Vaccines 2012: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry. The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines experienced strong growth through 2011 and this is expected to continue through the forecast period. Growth is being fueled by new product introductions and rising usage in all regions. Included in this report are current market size and forecast for the following vaccines: Pediatric Vaccines: •Combinations •Hepatitis •HIB •MMR •Pneumococcal •Poliovirus •Varicella •Other Pediatric Adult Vaccines:
• 2.
  •Cervical Cancer •Hepatitis •Influenza •Pneumococcal •Travel; DT;Misc. Kalorama has expanded the global perspective of this report in this edition, including estimates of vaccine sales (pediatric and adult segments) in the following regions: •U.S. •Rest of North Amer. •South America •Europe •Japan •India •China •Rest of World Despite ongoing improvements in pediatric vaccination, it is estimated that at least two million children die each year from diseases that could have been prevented by already existing vaccines. This problem is most significant in low income countries, with the health disparity between rich and poor countries resulting in average life spans of about 77 and 52 years, respectively. In addition to this high death toll, millions more suffer disability and illness because they have not been immunized. Adult immunization is an important, but frequently overlooked, part of patient care. Vaccination programs typically focus on children, yet adults in industrialized countries are more likely to die as a result of vaccine-preventable diseases than are children. Key issues in the global vaccine market today include product safety, refusal to immunize, supply shortages, the use of vaccines to prevent pandemics and address bioterrorism, and innovations in vaccine delivery systems.The following issues are discussed in this report. •Vaccine Safety •Refusal to Immunize •Obesity •Post-Licensure Surveillance •The Future of Vaccine Safety •Vaccine Shortages •Preventing Pandemics •Project Bioshield Act •National Bio and Agro-Defense Facility •DNA Vaccination •Mucosal Delivery •Intranasal Delivery •Vaccine Patches •Vaccine Chips and Microneedles
• 3.
  •Innovations in VaccineProduction •Nanoparticle Systems •Cloning Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission.For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Pharmacoeconomic studies have demonstrated the value of influenza and pneumococcal vaccines; however, immunization rates for these diseases continue to be low in the elderly populations. This report includes profiles of the key players in vaccines, including: •AlphaVax, Inc. •Bavarian Nordic A/S •Baxter Healthcare •Bharat Biotech •Crucell /Johnson & Johnson •Emergent biosolutions •GlaxoSmithKline •Medimmune •Merck & Co. Inc •Novartis •Sanofi Pasteur •Pfizer Get your copy of this report @ http://www.reportsnreports.com/reports/195649-vaccines-2012-world-market-analysis-key-players-trends-pediatric- and-adult-segments.html Major points covered in Table of Contents of this report include Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND TRENDS Introduction to Vaccines THE IMMUNE RESPONSE
• 4.
  MECHANISM OF ACTION (Table)Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2011 A BRIEF HISTORY: THE DEVELOPMENT OF VACCINES TYPES OF VACCINES Attenuated (Weakened) Live Viruses (Table) Vaccine-Preventable Diseases, August 2012 Killed (Inactivated) Viruses Toxoid Vaccines Genetically Engineered/Modified Vaccines VACCINE APPROVAL PROCESS (Table) VAERS Table of Reportable Events Following Vaccination Pediatric Preventive Vaccines INTRODUCTION (Table) Global Immunization Rates by Vaccine Type 2010 CHILDHOOD IMMUNIZATION IN THE UNITED STATES (Table) Immunization Profile of the United States: Population by Age Group, Number of Vaccine- Preventable Diseases Reported by Disease 1990 - 2010 Childhood Immunization Rates Challenges to the Vaccine Delivery System The Effect of U.S. Healthcare Reform Recommended Childhood Immunization Schedule (Table) U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2012 (Table) U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2012 State Immunization Recommendations United Nations Initiatives PEDIATRIC VACCINE PRODUCTS BCG Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio Haemophilus Influenzae Type B Hepatitis A Measles, Mumps and Rubella Meningococcal Disease Pneumococcal Conjugate Rotavirus Varicella PEDIATRIC VACCINES IN DEVELOPMENT COST OF VACCINES IN THE UNITED STATES (Table) Selected Pediatric Vaccines in Development, August 2012 THEWORLD MARKET FOR PEDIATRIC PREVENTIVE VACCINES Total Market Size and Forecast (Table) World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combinations,
• 5.
  Pneumococcal, Polio, Varicella,Others) 2007-2016 Revenues (in millions) (Table) World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2006-2015 Revenues (in millions) Hepatitis Vaccine Market (Table) World Pediatric Hepatitis Vaccine Market 2007-2016 Haemophilus Influenzae Type B Vaccine Market (Table) World Hib Vaccine Market, 2007-2016 Measles, Mumps and Rubella Vaccines (Table) World MMR Vaccines Market 2007-2016 Combination Vaccines Market (Table) World Combination Vaccines Market 2007-2016 Pneumococcal Vaccine (Table) World Pediatric Pneumococcal Vaccine Market 2007-2016 Poliovirus Vaccine (Table) World Poliovirus Vaccine Market 2007-2016 Varicella Vaccines (Table) World Varicella Vaccine Market 2007-2016 Other Vaccines Market (Table) World Pediatric Other Vaccines Market 2007-2016 Adult Preventive Vaccines INTRODUCTION ADULT VACCINE-PREVENTABLE DISEASES: FACTS AND FIGURES GLOBAL INFLUENZA SURVEILLANCE PROGRAM U.S. Surveillance RECOMMENDATIONS FOR ADULT IMMUNIZATIONS (Table) Universal Adult Immunization Schedule 2012 (Table) Summary of Recommendations for Adult Immunization ADULT VACCINE PRODUCTS Cervical Cancer (Table) Initiatives to Require HPV Vaccination by U.S. State, 2012 Cholera Diphtheria-Tetanus Hepatitis Influenza (Table) WHO Pandemic Classification Schedule Japanese Encephalitis Pneumococcal Disease Rabies Shingles Typhoid Fever Yellow Fever
• 6.
  ADULT VACCINES INDEVELOPMENT (Table) Selected Adult Preventive Vaccines in Development, 2012 THEWORLD MARKET FOR ADULT PREVENTIVE VACCINES Total Market Size and Forecast (Table) World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2007-2016 Revenues (in millions) (Table) World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2007-2016 Revenues (in millions) Cervical Cancer Market (Table) World Cervical CancerVaccine Market 2007-2016 Hepatitis Market (Table) World Hepatitis Vaccine Market 2007-2016 Influenza Vaccine Market (Table) World Influenza Vaccine Market 2007-2016 (Table) 2011 Estimated Population by Region and Selected Age Group (in millions) (Table) World Pneumococcal Vaccine Market 2007-2016 Travel, DT, and Miscellaneous Vaccine Market (Table) World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2007-2016 Vaccines Market Summary TRENDS DRIVING THE VACCINES MARKET MARKET SIZE AND FORECAST (Table) The World Vaccines Market by Vaccine Type 2007-2016 Revenues (in millions) Vaccine Sales by Region Vaccine Market Competitors (Table) The World Vaccines Market by Region (U.S., North America, South America, EU, Japan, India, China, ROW) 2007-2016 Revenues in millions (Table) Major Manufacturers' Shares of the World Vaccine Market, 2011 Pediatric Vaccines (Table) Major Manufacturer's Shares of the World Pediatric Vaccine Market 2011 Adult Vaccines (Table) Major Manufacturer's Shares of the World Adult Vaccine Market 2011 Issues and Trends VACCINE SAFETY Refusal to Immunize Obesity Post-Licensure Surveillance The Vaccine Injury Compensation Program World Health Organization Other Initiatives The Future of Vaccine Safety
• 7.
  VACCINE SHORTAGES Preventing Shortagesin the Developed Countries Preventing Shortages in Developing Nations PREVENTING PANDEMICS U.S. National Vaccine Plan VACCINES AND BIOTERRORISM Overview Project Bioshield Act (Table) Selected Companies/Laboratories Developing Biodefense Vaccines National Bio and Agro-Defense Facility Vaccine Treatment and Evaluation Units Anthrax Smallpox DNA VACCINATION INNOVATIONS IN VACCINE DELIVERY SYSTEMS Mucosal Delivery Intranasal Delivery Vaccine Patches Vaccine Chips and Microneedles INNOVATIONS IN VACCINE PRODUCTION Plants Insects Nanoparticle Systems Cloning Company Profiles ALPHAVAX, INC. History and Lines of Business Strategic Alliances Vaccine Products Financial Information BAVARIAN NORDIC A/S History and Lines of Business Strategic Alliances Vaccine Products Financial Information BAXTER HEALTHCARE History and Lines of Business Strategic Alliances Vaccine Products Financial Information BHARAT BIOTECH
• 8.
  History and Linesof Business Strategic Alliances Vaccine Products Financial Information CRUCELL /JOHNSON &JOHNSON History and Lines of Business Strategic Alliances Vaccine Products Financial Information EMERGENT BIOSOLUTIONS History and Lines of Business Strategic Alliances Vaccine Products Financial GLAXOSMITHKLINE History and Lines of Business Strategic Alliances Vaccine Products Financial Information MEDIMMUNE History and Lines of Business Strategic Alliances Vaccine Products Financial Information MERCK&CO. INC History and Lines of Business Strategic Alliances Vaccine Products Financial Information NOVARTIS History and Lines of Business Strategic Alliances Vaccine Products Financial Information History and Lines of Business Strategic Alliances Vaccine Products Financial Information SANOFI PASTEUR History and Lines of Business Strategic Alliances Vaccine Products
• 9.
  Financial Information Company Directory Contact:[email protected] for more information.